Comment from Disability Rights Education and Defense Fund
AnonymousSupportAdvocacy
Summary: The Disability Rights Education and Defense Fund (DREDF) supports the petition to remove the mifepristone Shared System Risk Evaluation and Mitigation Strategy (REMS) and its in-person dispensing requirement. They argue that reinstating such requirements would create illegal structural barriers to healthcare for people with disabilities, violating federal disability rights laws and the Food and Drug Administration Amendments Act.
See attached comments from the Disability Rights Education and Defense Fund (DREDF) in Support of Citizen Petition FDA-2025-P-0377-0001.